170 related articles for article (PubMed ID: 37290595)
1. The effect of exenatide (a GLP-1 analogue) and sitagliptin (a DPP-4 inhibitor) on asymmetric dimethylarginine (ADMA) metabolism and selected biomarkers of cardiac fibrosis in rats with fructose-induced metabolic syndrome.
Wójcicka G; Pradiuch A; Fornal E; Stachniuk A; Korolczuk A; Marzec-Kotarska B; Nikolaichuk H; Czechowska G; Kozub A; Trzpil A; Góralczyk A; Bełtowski J
Biochem Pharmacol; 2023 Aug; 214():115637. PubMed ID: 37290595
[TBL] [Abstract][Full Text] [Related]
2. The impact of sitagliptin, inhibitor of dipeptidyl peptidase-4 (DPP-4), on the ADMA-DDAH-NO pathway in ischemic and reperfused rat livers.
Trocha M; Nowak B; Merwid-Ląd A; Szuba A; Dzięgiel P; Pieśniewska M; Gomułkiewicz A; Wiśniewski J; Piasecki T; Gziut M; Szeląg A; Sozański T
Adv Clin Exp Med; 2018 Nov; 27(11):1483-1490. PubMed ID: 30303311
[TBL] [Abstract][Full Text] [Related]
3. The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats.
Wójcicka G; Zaręba M; Warpas A; Jamroz-Wiśniewska A; Rusek M; Czechowska G; Bełtowski J
Eur J Pharmacol; 2019 May; 850():180-189. PubMed ID: 30768981
[TBL] [Abstract][Full Text] [Related]
4. Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction.
Esposito G; Cappetta D; Russo R; Rivellino A; Ciuffreda LP; Roviezzo F; Piegari E; Berrino L; Rossi F; De Angelis A; Urbanek K
Br J Pharmacol; 2017 Nov; 174(22):4070-4086. PubMed ID: 27922176
[TBL] [Abstract][Full Text] [Related]
5. Positive Effects of Melatonin on Renal Nitric Oxide-Asymmetric Dimethylarginine Metabolism in Fructose-Fed Rats.
Pasaoglu OT; Bircan FS; Topal T; Turkozkan N
Metab Syndr Relat Disord; 2021 Apr; 19(3):120-126. PubMed ID: 33090894
[No Abstract] [Full Text] [Related]
6. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
7. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
Zhu ZD; Ye JM; Fu XM; Wang XC; Ye JY; Wu XR; Hua P; Liao YQ; Xuan W; Duan JL; Li WY; Fu H; Xia ZH; Zhang X
Int J Mol Med; 2019 Feb; 43(2):749-760. PubMed ID: 30569164
[TBL] [Abstract][Full Text] [Related]
8. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
9. Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model.
Al-Awar A; Almási N; Szabó R; Takacs I; Murlasits Z; Szűcs G; Török S; Pósa A; Varga C; Kupai K
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340421
[TBL] [Abstract][Full Text] [Related]
10. Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y⁺LAT2 Carrier-Mediated Loss.
Milewski K; Bogacińska-Karaś M; Fręśko I; Hilgier W; Jaźwiec R; Albrecht J; Zielińska M
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099056
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of low-dose rosuvastatin on isoproterenol-induced chronic heart failure in rats by regulation of DDAH-ADMA-NO pathway.
Zhou R; Ma P; Xiong A; Xu Y; Wang Y; Xu Q
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27957828
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of dipeptidyl peptidase-4 inhibitors in testicular torsion/detorsion in rats: a possible role of HIF-1α and nitric oxide.
Abdelzaher WY; Rofaeil RR; Ali DME; Attya ME
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):603-614. PubMed ID: 31773182
[TBL] [Abstract][Full Text] [Related]
13. Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats.
Liu YS; Huang ZW; Wang L; Liu XX; Wang YM; Zhang Y; Zhang M
J Pharmacol Sci; 2015 Mar; 127(3):260-74. PubMed ID: 25837922
[TBL] [Abstract][Full Text] [Related]
14. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine is positively related to nitric oxide level in tissues of normotensive and hypertensive rats.
Szlęzak D; Ufnal M; Drapała A; Samborowska E; Wróbel M
Amino Acids; 2023 Apr; 55(4):529-539. PubMed ID: 36802034
[TBL] [Abstract][Full Text] [Related]
16. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
Tan B; Jiang DJ; Huang H; Jia SJ; Jiang JL; Hu CP; Li YJ
Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168
[TBL] [Abstract][Full Text] [Related]
17. Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes.
Mikhail N
Expert Opin Investig Drugs; 2008 Jun; 17(6):845-53. PubMed ID: 18491986
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
Wakino S; Hayashi K; Tatematsu S; Hasegawa K; Takamatsu I; Kanda T; Homma K; Yoshioka K; Sugano N; Saruta T
Hypertens Res; 2005 Mar; 28(3):255-62. PubMed ID: 16097370
[TBL] [Abstract][Full Text] [Related]
20. Lack of preservation of insulin gene expression by a glucagon-like peptide 1 agonist or a dipeptidyl peptidase 4 inhibitor in an in vivo model of glucolipotoxicity.
Fontés G; Hagman DK; Latour MG; Semache M; Poitout V
Diabetes Res Clin Pract; 2010 Mar; 87(3):322-8. PubMed ID: 20092903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
